Gilder Gagnon Howe & Co. LLC trimmed its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 4.6% during the second quarter, Holdings Channel reports. The firm owned 177,752 shares of the medical equipment provider’s stock after selling 8,514 shares during the period. Gilder Gagnon Howe & Co. LLC’s holdings in Intuitive Surgical were worth $101,288,000 as of its most recent filing with the Securities and Exchange Commission.
Other institutional investors also recently made changes to their positions in the company. Wellington Management Group LLP increased its position in Intuitive Surgical by 428.9% in the 1st quarter. Wellington Management Group LLP now owns 1,433,496 shares of the medical equipment provider’s stock valued at $709,882,000 after acquiring an additional 1,162,469 shares during the period. Capital World Investors boosted its position in shares of Intuitive Surgical by 13.5% in the first quarter. Capital World Investors now owns 4,969,285 shares of the medical equipment provider’s stock worth $2,460,849,000 after buying an additional 591,816 shares during the period. Girard Partners LTD. acquired a new stake in shares of Intuitive Surgical in the first quarter worth $631,000. Sustainable Growth Advisers LP acquired a new stake in shares of Intuitive Surgical in the first quarter worth $236,924,000. Finally, Fisher Asset Management LLC boosted its position in shares of Intuitive Surgical by 59.5% in the second quarter. Fisher Asset Management LLC now owns 1,127,342 shares of the medical equipment provider’s stock worth $642,393,000 after buying an additional 420,411 shares during the period. Institutional investors and hedge funds own 86.94% of the company’s stock.
Shares of ISRG traded down $6.33 on Friday, hitting $735.28. The company’s stock had a trading volume of 827,209 shares, compared to its average volume of 527,124. The company has a market capitalization of $86.79 billion, a PE ratio of 77.32, a PEG ratio of 12.93 and a beta of 0.97. Intuitive Surgical, Inc. has a fifty-two week low of $360.50 and a fifty-two week high of $778.83. The company has a 50 day moving average price of $689.72 and a 200 day moving average price of $574.33.
Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Tuesday, July 21st. The medical equipment provider reported $1.11 EPS for the quarter, topping the consensus estimate of $0.59 by $0.52. The business had revenue of $852.10 million for the quarter, compared to the consensus estimate of $675.15 million. Intuitive Surgical had a return on equity of 13.62% and a net margin of 26.07%. During the same period in the previous year, the business earned $3.25 EPS. On average, research analysts predict that Intuitive Surgical, Inc. will post 7.09 earnings per share for the current fiscal year.
In related news, Director Alan J. Levy sold 1,800 shares of the business’s stock in a transaction that occurred on Tuesday, July 21st. The shares were sold at an average price of $670.71, for a total value of $1,207,278.00. Also, EVP David J. Rosa sold 17,950 shares of the business’s stock in a transaction that occurred on Monday, June 15th. The stock was sold at an average price of $553.49, for a total transaction of $9,935,145.50. Following the completion of the transaction, the executive vice president now owns 37,269 shares of the company’s stock, valued at approximately $20,628,018.81. The disclosure for this sale can be found here. Insiders sold a total of 47,830 shares of company stock worth $30,439,933 over the last three months. 1.60% of the stock is owned by company insiders.
A number of research firms recently issued reports on ISRG. JPMorgan Chase & Co. lifted their price objective on Intuitive Surgical from $600.00 to $700.00 and gave the company an “overweight” rating in a research report on Wednesday, July 22nd. Deutsche Bank lifted their price objective on Intuitive Surgical from $500.00 to $600.00 and gave the stock a “hold” rating in a research note on Wednesday, July 22nd. OTR Global downgraded Intuitive Surgical to a “positive” rating in a research report on Tuesday, June 16th. Stifel Nicolaus lifted their target price on Intuitive Surgical from $575.00 to $715.00 and gave the stock a “buy” rating in a research report on Monday, July 20th. Finally, Sanford C. Bernstein lifted their target price on Intuitive Surgical from $625.00 to $725.00 and gave the stock an “outperform” rating in a research report on Monday, July 20th. Three research analysts have rated the stock with a sell rating, eight have issued a hold rating, thirteen have assigned a buy rating and two have given a strong buy rating to the company. Intuitive Surgical has a consensus rating of “Buy” and an average price target of $664.84.
About Intuitive Surgical
Intuitive Surgical, Inc designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. Its da Vinci Surgical System transforms the surgeon's natural hand movements outside the body into corresponding micro-movements inside the patient's body. The company's da Vinci Surgical System include surgeon's consoles, patient-side carts, 3-D vision systems, da Vinci skills simulators, da Vinci Xi integrated table motions, and Firefly fluorescence imaging products that enable surgeons to perform various surgical procedures, including gynecologic, urologic, general, cardiothoracic, and head and neck surgical procedures.
Recommended Story: Buyback
Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG).
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.